News About: Goverment
Drug Utilization Review system to be expanded nationwide
The government is considering expanding the current Drug Utilization Review (DUR) system nationwide, possibly within December 2011. The system will also cover over-the-counter drugs.
The Ministry of Health and Welf...
Korea to upgrade drug compendium
The Korea Food and Drug Administration has upgraded a variety of local drug compendiums, including Korea Pharmacopoeia (KP), to the international level as the harmonization on the international specification standards...
Korea urged to support pharmaceutical industry
The government has recently pledged to promote the biosimilar industry, aiming to take 22 percent of the global market by 2020, but experts said that it is necessary for the government to provide more positive support...
Court dismisses drugmakers’ appeal on rebate related fines
An appeal by Yuhan Corp. Hanmi Pharmaceutical and Choongwae Pharmaceutical against the Fair Trade Commission (FTC)’s decision to impose fines was dismissed by the Supreme Court.
The court said on November 25 it dis...
KFDA to set up stringent guideline on diet pills
The Korea food and Drug Administration is considering establishing a new guideline to strictly control obesity drugs, such as psychotropic drugs, which have been used to treat obesity.
Korea has banned sales of con...
Hemophila patients call for lifting age restriction over insurance of Kogenate FS
Will hemophila patients be able to get cheaper and better drugs this year?
Now all eyes are on the Ministry for Health, Welfare and Family Affair's decision on the insurance price of Kogenate FS, a new drug for th...
Local drug makers mulls remuneration over API manufacturer
With the new DMF (drug master file) system to take effect next year, local drug manufacturers are considering paying any royalty-like money to DMF-endorsed API (active pharmaceutical ingredient) manufacturers, to get ...
Cabinet endorses bill on license of healthcare providers
The government on Tuesday approved a bill allowing those suffering from mild depression, except for patients with serious mental disorder, to get a doctor or pharmacist license without restriction, stepping up efforts...
Prices of 254 antihypertensive agents to be reduced from next January
The Ministry of Health and Welfare says health insurance prices of 254 antihypertensive medications, including Cozzar, will be reduced from January 2011 to January 2013.
The lowered drug prices are expected to help h...
Health insurance premium to rise 6%
The national health insurance premium will go up by 5.9 percent from next year, the Ministry of Health and Welfare announced on November 22.
A ministry spokesperson said the hike was inevitable because medical fee...
